Claims for Patent: 5,869,279

Summary for Patent: 5,869,279

Title:	Modified porphyroproteins
Abstract:	Hemin-like porphyrins can be prepared from chlorophylls and hemin, which may be used as intermediates to form functionally active porphyroproteins. The porphyrins can be reacted with apoproteins in vitro or added to a cell culture and combined intracellularly with apoproteins to form functionally active porphyroproteins.
Inventor(s):	Camiener; Gerald W. (Solon, OH)
Assignee:
Application Number:
Patent Claims:	1. A method of producing an animal-associated porphyrin, comprising extracting a plant-associated porphyrin from photosynthetic cells, and converting said plant-associated porphyrin in vitro into said animal-associated porphyrin. 2. The method of claim 1, wherein said plant-associated porphyrin is selected from the group consisting of a chlorophyll and plant-produced porphyrins. 3. The method of claim 2, wherein the plant-produced porphyrin is protoporhyrin IX. 4. The method of claim 1, wherein said animal-associated porphyrin is a metalloporphyrin. 5. The method of claim 4, wherein said metalloporphyrin is hemin.

Details for Patent 5,869,279

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	07/20/1983		2010-06-14